Piperacillin and Tazobactam
- Product NDC
- 70860-121
- 11-digit product format
- 708600121
- Labeler code
- 70860
- Product ID
- 70860-121_643b904f-0c6a-4c3f-8b92-4afdde694829
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- piperacillin and tazobactam
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA065523
- Marketing category
- ANDA
- Marketing start
- 2019-02-05
- Marketing end
- 0000-00-00
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 3 g/15mL; g/15mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-121-30 | 70860012130 | 10 VIAL in 1 CARTON (70860-121-30) > 15 mL in 1 VIAL (70860-121-41) | 10 vial | 2019-02-05 | 0000-00-00 | No | No | Current |